Literature DB >> 23629539

Diagnosis and treatment of growth hormone deficiency in adults.

Atil Y Kargi1, George R Merriam.   

Abstract

The availability of synthetic recombinant human growth hormone (GH) in potentially unlimited quantities since the 1980s has improved understanding of the many nonstatural effects of GH on metabolism, body composition, physical and psychological function, as well as the consequences of GH deficiency in adult life. Adult GH deficiency is now recognized as a distinct if nonspecific syndrome with considerable adverse health consequences. GH replacement therapy in lower doses than those used in children can reverse many of these abnormalities and restore functional capacities toward or even to normal; if dosed appropriately, GH therapy has few adverse effects. Although some doubts remain about possible long-term risks of childhood GH therapy, most registries of adult GH replacement therapy, albeit limited in study size and duration, have not shown an increased incidence of cancers or of cardiovascular morbidity or mortality.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23629539     DOI: 10.1038/nrendo.2013.77

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  136 in total

1.  The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. .

Authors:  C Wüster; R Abs; B A Bengtsson; H Bennmarker; U Feldt-Rasmussen; E Hernberg-Ståhl; J P Monson; B Westberg; P Wilton
Journal:  J Bone Miner Res       Date:  2001-02       Impact factor: 6.741

2.  Incidence of growth hormone deficiency.

Authors:  J M Parkin
Journal:  Arch Dis Child       Date:  1974-11       Impact factor: 3.791

3.  Diagnosis of growth hormone deficiency in adults by testing with GHRP-6 alone or in combination with GHRH: comparison with the insulin tolerance test.

Authors:  Stephan Petersenn; Roman Jung; Frank U Beil
Journal:  Eur J Endocrinol       Date:  2002-05       Impact factor: 6.664

4.  Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline.

Authors:  Mark E Molitch; David R Clemmons; Saul Malozowski; George R Merriam; Mary Lee Vance
Journal:  J Clin Endocrinol Metab       Date:  2011-06       Impact factor: 5.958

Review 5.  Diagnosis of severe growth hormone (GH) deficiency in young adults who received GH replacement therapy during childhood.

Authors:  A A Toogood; S M Shalet
Journal:  Acta Paediatr Suppl       Date:  1997-11

6.  The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH.

Authors:  Agatha A van der Klaauw; Nienke R Biermasz; Edith J M Feskens; Marieke B Bos; Johannes W A Smit; Ferdinand Roelfsema; Eleonora P M Corssmit; Hanno Pijl; Johannes A Romijn; Alberto M Pereira
Journal:  Eur J Endocrinol       Date:  2007-04       Impact factor: 6.664

7.  Consequences of childhood-onset growth hormone deficiency for adult bone mass.

Authors:  H de Boer; G J Blok; A van Lingen; G J Teule; P Lips; E A van der Veen
Journal:  J Bone Miner Res       Date:  1994-08       Impact factor: 6.741

8.  Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults.

Authors:  Joselina L M Oliveira; Manuel H Aguiar-Oliveira; Argemiro D'Oliveira; Rossana M C Pereira; Carla R P Oliveira; Catarine T Farias; José A Barreto-Filho; Fernando D Anjos-Andrade; Celi Marques-Santos; Adão C Nascimento-Junior; Erica O Alves; Francielle T Oliveira; Viviane C Campos; Roberto Ximenes; Amanda Blackford; Giovanni Parmigiani; Roberto Salvatori
Journal:  J Clin Endocrinol Metab       Date:  2007-10-02       Impact factor: 5.958

9.  Mortality and GH deficiency: a nationwide study.

Authors:  Kirstine Stochholm; Claus Højbjerg Gravholt; Torben Laursen; Peter Laurberg; Marianne Andersen; Lars Østergaard Kristensen; Ulla Feldt-Rasmussen; Jens Sandahl Christiansen; Morten Frydenberg; Anders Green
Journal:  Eur J Endocrinol       Date:  2007-07       Impact factor: 6.664

10.  Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study.

Authors:  Christopher J Child; Alan G Zimmermann; Whitney W Woodmansee; Daniel M Green; Jian J Li; Heike Jung; Eva Marie Erfurth; Leslie L Robison
Journal:  Eur J Endocrinol       Date:  2011-06-06       Impact factor: 6.664

View more
  30 in total

1.  Protein Extraction by Means of Electroporation from E. coli with Preserved Viability.

Authors:  Sasa Haberl Meglic; Tilen Marolt; Damijan Miklavcic
Journal:  J Membr Biol       Date:  2015-07-23       Impact factor: 1.843

2.  Human growth hormone promotes corneal epithelial cell migration in vitro.

Authors:  Juan Ding; Barbara Wirostko; David A Sullivan
Journal:  Cornea       Date:  2015-06       Impact factor: 2.651

3.  Severe growth hormone deficiency and empty sella in obesity: a cross-sectional study.

Authors:  Carla Lubrano; Marta Tenuta; Daniela Costantini; Palma Specchia; Giuseppe Barbaro; Sabrina Basciani; Stefania Mariani; Alfredo Pontecorvi; Andrea Lenzi; Lucio Gnessi
Journal:  Endocrine       Date:  2015-01-23       Impact factor: 3.633

4.  Intermittent hypoxia suppression of growth hormone and insulin-like growth factor-I in the neonatal rat liver.

Authors:  Charles Cai; Taimur Ahmad; Gloria B Valencia; Jacob V Aranda; Jiliu Xu; Kay D Beharry
Journal:  Growth Horm IGF Res       Date:  2018-03-08       Impact factor: 2.372

5.  Muscle-specific deletion of signal transducer and activator of transcription 5 augments lipid accumulation in skeletal muscle and liver of mice in response to high-fat diet.

Authors:  Myunggi Baik; Mi Sun Lee; Hyeok Joong Kang; Seung Ju Park; Min Yu Piao; Trang Hoa Nguyen; Lothar Hennighausen
Journal:  Eur J Nutr       Date:  2015-11-18       Impact factor: 5.614

6.  Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance.

Authors:  Artur Galimov; Angelika Hartung; Roman Trepp; Alexander Mader; Martin Flück; Axel Linke; Matthias Blüher; Emanuel Christ; Jan Krützfeldt
Journal:  J Mol Med (Berl)       Date:  2015-07-23       Impact factor: 4.599

7.  Validation of serum IGF-I as a biomarker to monitor the bioactivity of exogenous growth hormone agonists and antagonists in rabbits.

Authors:  Maximilian Bielohuby; Sayyed Hamid Zarkesh-Esfahani; Jenny Manolopoulou; Elisa Wirthgen; Katja Walpurgis; Mohaddeseh Toghiany Khorasgani; Zahra Sadat Aghili; Ian Robert Wilkinson; Andreas Hoeflich; Mario Thevis; Richard J Ross; Martin Bidlingmaier
Journal:  Dis Model Mech       Date:  2014-09-19       Impact factor: 5.758

8.  Adult growth hormone deficiency - benefits, side effects, and risks of growth hormone replacement.

Authors:  Mary L Reed; George R Merriam; Atil Y Kargi
Journal:  Front Endocrinol (Lausanne)       Date:  2013-06-04       Impact factor: 5.555

Review 9.  Impaired Pituitary Axes Following Traumatic Brain Injury.

Authors:  Robert A Scranton; David S Baskin
Journal:  J Clin Med       Date:  2015-07-13       Impact factor: 4.241

Review 10.  The Burden of Hormonal Disorders: A Worldwide Overview With a Particular Look in Italy.

Authors:  Andrea Crafa; Aldo E Calogero; Rossella Cannarella; Laura M Mongioi'; Rosita A Condorelli; Emanuela A Greco; Antonio Aversa; Sandro La Vignera
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.